2m 2m 2m 2m 2m 2m 2m
KORU Medical Sys (KRMD)
NASDAQ
$4.08+$0.16 (+4.11%)
Price as of Jun 03, 2026 7:58 PM EDT- $186.5MMarket Cap
- 42.61%1-Year Change
- Medical Instruments & SuppliesIndustry
KORU Medical Sys (KRMD)
$4.08+$0.16 (+4.11%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 41.1M +22.23% | 33.6M +17.98% | 28.5M +2.23% | 27.9M +18.76% | |
Cost of Revenue | 15.5M +26.06% | 12.3M +4.28% | 11.8M -5.73% | 12.5M +28.87% | |
Gross Profit | 25.6M +20.03% | 21.3M +27.67% | 16.7M +8.71% | 15.4M +11.62% | |
Sales and Marketing Expense | 23.4M +8.08% | 21.6M +6.22% | 20.4M -1.17% | 20.6M +15.36% | |
Research and Development Expense | -4.4M -16.56% | -5.3M -8.43% | -5.7M +15.86% | -5.0M +100.36% | |
Depreciation and Amortization Expense | 810,500 -8.78% | 888,473 +2.08% | 870,390 +48.24% | 587,137 +26.78% | |
Total Operating Expenses | 28.6M +2.87% | 27.8M +2.96% | 27.0M +3.17% | 26.1M +25.73% | |
Operating Profit | -3.0M -53.89% | -6.4M -37.23% | -10.3M -4.74% | -10.8M +53.37% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 356,406 -6.82% | 382,491 -22.95% | 496,397 +369.57% | 105,713 -84.11% | |
Income before Taxes | -2.6M -56.86% | -6.1M -37.96% | -9.8M -8.45% | -10.7M -267.73% | |
Income Taxes | 21,890 +656.65% | 2,893 -99.93% | 4.0M +296.99% | -2.0M -211.79% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | N/A N/A | -6.1M -55.85% | -13.7M +58.65% | -8.7M +89.82% | |
Net Income from Continuing Operations Applicable to Common | -2.6M -56.88% | -6.1M -55.85% | -13.7M +58.65% | -8.7M +89.82% | |
Basic EPS and Net Income | -0.06 -53.85% | -0.13 -56.67% | -0.30 +57.89% | -0.19 +90.00% | |
Diluted EPS and Net Income | -0.06 -53.85% | -0.13 -56.67% | -0.30 +57.89% | -0.19 +90.00% | |
Basic Weighted Average Shares | 46.2M +0.84% | 45.8M +0.44% | 45.6M +1.33% | 45.0M +1.39% | |
Diluted Weighted Average Shares | 46.2M +0.84% | 45.8M +0.44% | 45.6M +1.33% | 45.0M +1.39% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 8.9M -7.40% | 9.6M -16.56% | 11.5M -34.04% | 17.4M -31.29% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 8.9M -7.40% | 9.6M -16.56% | 11.5M -34.04% | 17.4M -31.29% | |
Total Current Assets | 20.0M +4.48% | 19.1M -5.55% | 20.3M -32.03% | 29.8M -20.15% | |
Accumulated Depreciation | 4.1M +17.11% | 3.5M +27.62% | 2.7M -2.62% | 2.8M +20.86% | |
Property and Plant and Equipment and Net | 4.5M +4.22% | 4.3M +11.80% | 3.8M -1.27% | 3.9M +251.30% | |
Total Long-Term Assets | 98,970 0.00% | 98,970 0.00% | 98,970 -3.56% | 102,625 +417.99% | |
Total Assets | 28.2M +3.61% | 27.2M -4.37% | 28.5M -32.77% | 42.3M +2.52% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 5.0M +1,743.98% | 271,152 -13.74% | 314,344 -27.45% | 433,295 -14.80% | |
Total Current Liabilities | 8.2M +13.78% | 7.2M +61.68% | 4.5M -35.99% | 7.0M +45.22% | |
Total Long-Term Debt | N/A N/A | N/A N/A | 884,344 +10.54% | 800,000 -11.11% | |
Total Long-Term Liabilities | 2.9M -4.04% | 3.0M -10.07% | 3.3M -8.68% | 3.7M +3,723.28% | |
Total Liabilities | 11.2M +7.18% | 10.4M +28.34% | 8.1M -26.34% | 11.0M +129.69% | |
Retained Earnings | -32.0M +8.98% | -29.4M +26.02% | -23.3M +143.57% | -9.6M +951.70% | |
Total Stockholders Equity | 17.0M +1.39% | 16.8M -17.39% | 20.4M -35.03% | 31.3M -14.18% | |
Total Shares Outstanding | 46.4M +0.90% | 46.0M +0.63% | 45.7M +0.50% | 45.4M +1.83% | |
Cash Flow | |||||
Cash from Operating Activities | 462,405 +244.63% | -319,718 -93.47% | -4.9M -9.47% | -5.4M +25.12% | |
Capital Expenditures | 932,517 -28.13% | 1.3M +65.71% | 782,949 -71.64% | 2.8M +697.58% | |
Cash from Investing Activities | -949,790 -28.75% | -1.3M +63.64% | -814,597 -70.92% | -2.8M +665.10% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -221,350 -10.94% | -248,533 +13.55% | -218,867 -178.31% | 279,485 -89.67% | |
Financials Ratio | |||||
Gross Margin | 62.26% -1.81% | 63.40% +8.21% | 58.59% +6.34% | 55.09% -6.01% | |
Operating Margin | -7.23% -62.28% | -19.16% -46.80% | -36.01% -6.82% | -38.65% +29.14% | |
Return on Assets | N/A N/A | -21.79% -43.87% | -38.82% +87.41% | -20.71% +84.34% | |
Return on Equity | N/A N/A | -32.64% -38.61% | -53.18% +108.22% | -25.54% +103.34% | |
Revenue Growth | 22.23% +23.63% | 17.98% +707.06% | 2.23% -88.12% | 18.76% +760.76% | |
Current Ratio | 2.44 -8.18% | 2.66 -41.58% | 4.55 +6.19% | 4.28 -45.01% | |
Cash Ratio | 1.08 -18.62% | 1.33 -48.39% | 2.58 +3.05% | 2.50 -52.68% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | 0.06 +49.49% | 0.04 +2.07% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 0.04 +44.67% | 0.03 -14.66% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow